These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 21706448

  • 1. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.
    Provaznikova D, Rittich S, Malina M, Seeman T, Marinov I, Riedl M, Hrachovinova I.
    Pediatr Nephrol; 2012 Jan; 27(1):73-81. PubMed ID: 21706448
    [Abstract] [Full Text] [Related]

  • 2. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
    Bresin E, Rurali E, Caprioli J, Sanchez-Corral P, Fremeaux-Bacchi V, Rodriguez de Cordoba S, Pinto S, Goodship TH, Alberti M, Ribes D, Valoti E, Remuzzi G, Noris M, European Working Party on Complement Genetics in Renal Diseases.
    J Am Soc Nephrol; 2013 Feb; 24(3):475-86. PubMed ID: 23431077
    [Abstract] [Full Text] [Related]

  • 3. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
    Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G.
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1844-59. PubMed ID: 20595690
    [Abstract] [Full Text] [Related]

  • 4.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Noris M, Bresin E, Mele C, Remuzzi G.
    ; 1993 Oct. PubMed ID: 20301541
    [Abstract] [Full Text] [Related]

  • 5. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C.
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [Abstract] [Full Text] [Related]

  • 6. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
    Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ.
    Hum Mutat; 2010 Jun; 31(6):E1445-60. PubMed ID: 20513133
    [Abstract] [Full Text] [Related]

  • 7. Rapid recovery of membrane cofactor protein (MCP; CD46) associated atypical haemolytic uraemic syndrome with plasma exchange.
    Reid VL, Mullan A, Erwig LP.
    BMJ Case Rep; 2013 Sep 04; 2013():. PubMed ID: 24005975
    [Abstract] [Full Text] [Related]

  • 8. Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome.
    Fan X, Yoshida Y, Honda S, Matsumoto M, Sawada Y, Hattori M, Hisanaga S, Hiwa R, Nakamura F, Tomomori M, Miyagawa S, Fujimaru R, Yamada H, Sawai T, Ikeda Y, Iwata N, Uemura O, Matsukuma E, Aizawa Y, Harada H, Wada H, Ishikawa E, Ashida A, Nangaku M, Miyata T, Fujimura Y.
    Mol Immunol; 2013 Jun 04; 54(2):238-46. PubMed ID: 23314101
    [Abstract] [Full Text] [Related]

  • 9. Atypical hemolytic uremic syndrome.
    Loirat C, Frémeaux-Bacchi V.
    Orphanet J Rare Dis; 2011 Sep 08; 6():60. PubMed ID: 21902819
    [Abstract] [Full Text] [Related]

  • 10. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.
    Le Quintrec M, Zuber J, Moulin B, Kamar N, Jablonski M, Lionet A, Chatelet V, Mousson C, Mourad G, Bridoux F, Cassuto E, Loirat C, Rondeau E, Delahousse M, Frémeaux-Bacchi V.
    Am J Transplant; 2013 Mar 08; 13(3):663-75. PubMed ID: 23356914
    [Abstract] [Full Text] [Related]

  • 11. Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics.
    Geerdink LM, Westra D, van Wijk JA, Dorresteijn EM, Lilien MR, Davin JC, Kömhoff M, Van Hoeck K, van der Vlugt A, van den Heuvel LP, van de Kar NC.
    Pediatr Nephrol; 2012 Aug 08; 27(8):1283-91. PubMed ID: 22410797
    [Abstract] [Full Text] [Related]

  • 12. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
    Fremeaux-Bacchi V, Moulton EA, Kavanagh D, Dragon-Durey MA, Blouin J, Caudy A, Arzouk N, Cleper R, Francois M, Guest G, Pourrat J, Seligman R, Fridman WH, Loirat C, Atkinson JP.
    J Am Soc Nephrol; 2006 Jul 08; 17(7):2017-25. PubMed ID: 16762990
    [Abstract] [Full Text] [Related]

  • 13. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
    Richards A, Kathryn Liszewski M, Kavanagh D, Fang CJ, Moulton E, Fremeaux-Bacchi V, Remuzzi G, Noris M, Goodship TH, Atkinson JP.
    Mol Immunol; 2007 Jan 08; 44(1-3):111-22. PubMed ID: 16882452
    [Abstract] [Full Text] [Related]

  • 14. Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations.
    Pabst WL, Neuhaus TJ, Nef S, Bresin E, Zingg-Schenk A, Spartà G.
    Pediatr Nephrol; 2013 Jul 08; 28(7):1141-4. PubMed ID: 23519521
    [Abstract] [Full Text] [Related]

  • 15. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome.
    Fang CJ, Fremeaux-Bacchi V, Liszewski MK, Pianetti G, Noris M, Goodship TH, Atkinson JP.
    Blood; 2008 Jan 15; 111(2):624-32. PubMed ID: 17914026
    [Abstract] [Full Text] [Related]

  • 16. A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic syndrome.
    Tawadrous H, Maga T, Sharma J, Kupferman J, Smith RJ, Schoeneman M.
    Pediatr Nephrol; 2010 May 15; 25(5):947-51. PubMed ID: 20108004
    [Abstract] [Full Text] [Related]

  • 17. The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome.
    Martinez-Barricarte R, Pianetti G, Gautard R, Misselwitz J, Strain L, Fremeaux-Bacchi V, Skerka C, Zipfel PF, Goodship T, Noris M, Remuzzi G, de Cordoba SR, European Working Party on the Genetics of HUS.
    J Am Soc Nephrol; 2008 Mar 15; 19(3):639-46. PubMed ID: 18235085
    [Abstract] [Full Text] [Related]

  • 18. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
    Hirt-Minkowski P, Dickenmann M, Schifferli JA.
    Nephron Clin Pract; 2010 Mar 15; 114(4):c219-35. PubMed ID: 20090363
    [Abstract] [Full Text] [Related]

  • 19. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
    Moore I, Strain L, Pappworth I, Kavanagh D, Barlow PN, Herbert AP, Schmidt CQ, Staniforth SJ, Holmes LV, Ward R, Morgan L, Goodship TH, Marchbank KJ.
    Blood; 2010 Jan 14; 115(2):379-87. PubMed ID: 19861685
    [Abstract] [Full Text] [Related]

  • 20. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
    Szarvas N, Szilágyi Á, Csuka D, Takács B, Rusai K, Müller T, Arbeiter K, Réti M, Haris Á, Wagner L, Török S, Kelen K, Szabó AJ, Reusz GS, Morgan BP, Prohászka Z.
    Mol Immunol; 2016 Mar 14; 71():10-22. PubMed ID: 26826462
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.